These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
4. [The changes in nuclear DNA amounts in the development and progression of uterine cervical cancer determined by cytofluorometry]. Harada K Nihon Sanka Fujinka Gakkai Zasshi; 1986 May; 38(5):759-68. PubMed ID: 3722955 [TBL] [Abstract][Full Text] [Related]
5. Measurement of tritiated thymidine labeling index by incubation in vitro of surgically removed cervical cancer. Sasaki K Gan; 1977 Jun; 68(3):307-13. PubMed ID: 913953 [TBL] [Abstract][Full Text] [Related]
6. Discrimination between precancerous and cancerous lesions of the uterine cervix by DNA measurements on tissue sections. Barres DR; Duhr MA; Boivin YA Anal Quant Cytol Histol; 1985 Dec; 7(4):320-6. PubMed ID: 3841484 [TBL] [Abstract][Full Text] [Related]
7. Nuclear DNA content of normal, neoplastic and "wart-affected" cervical biopsies. Evans AS; Monaghan JM Anal Quant Cytol; 1983 Jun; 5(2):112-6. PubMed ID: 6881760 [TBL] [Abstract][Full Text] [Related]
8. [DNA content in dysplasias and early invasive forms of cervical cancer]. Chebanu FA; Kushch AA; Zelenin AV Vopr Onkol; 1977; 23(12):64-6. PubMed ID: 602080 [TBL] [Abstract][Full Text] [Related]
9. [Cellular DNA content of human cervical carcinoma]. Zuo XL; Zhang L Zhonghua Fu Chan Ke Za Zhi; 1989 Sep; 24(5):288-90, 317. PubMed ID: 2620584 [TBL] [Abstract][Full Text] [Related]
10. The labelling index of human and mouse tumours assessed by bromodeoxyuridine staining in vitro and in vivo and flow cytometry. Wilson GD; McNally NJ; Dunphy E; Kärcher H; Pfragner R Cytometry; 1985 Nov; 6(6):641-7. PubMed ID: 4064843 [TBL] [Abstract][Full Text] [Related]
11. Flow cytometric determination of DNA content in malignant and benign bone tumours. Heliö H; Karaharju E; Nordling S Cytometry; 1985 Mar; 6(2):165-71. PubMed ID: 3979218 [TBL] [Abstract][Full Text] [Related]
12. [Tumor cell kinetics in uterine cervical carcinoma following irradiation]. Lin CS Nihon Sanka Fujinka Gakkai Zasshi; 1984 Nov; 36(11):2138-46. PubMed ID: 6512330 [TBL] [Abstract][Full Text] [Related]
13. Nuclear DNA content and the number of Barr bodies in premalignant and malignant lesions of the uterine cervix. Nishiya I; Ishizaki Y; Sasaki M Acta Cytol; 1981; 25(4):407-11. PubMed ID: 6945007 [TBL] [Abstract][Full Text] [Related]
14. Measurement of DNA content and of tritiated thymidine and bromodeoxyuridine incorporation by the same cells. Lin P; Allison DC J Histochem Cytochem; 1993 Sep; 41(9):1435-9. PubMed ID: 8354883 [TBL] [Abstract][Full Text] [Related]
15. Feulgen-DNA-values in transitional cell carcinoma of the human urinary bladder. Fossä SD Beitr Pathol; 1975 May; 155(1):44-55. PubMed ID: 1156320 [TBL] [Abstract][Full Text] [Related]
16. Can tumour response be assessed from a biopsy? Trott KR Br J Cancer Suppl; 1980 Apr; 4():163-70. PubMed ID: 7000119 [TBL] [Abstract][Full Text] [Related]
17. [The relationship between DNA content in cervical carcinoma cell and the clinicopathological features]. Zhang H Zhonghua Bing Li Xue Za Zhi; 1989 Jun; 18(2):137-9. PubMed ID: 2582553 [TBL] [Abstract][Full Text] [Related]
18. Effect of melanin bleach on Feulgen-DNA microdensitometry in pigmented lesions. Li LX; Crotty KA; Kril JJ; McCarthy SW; Palmer AA Anal Quant Cytol Histol; 2000 Apr; 22(2):150-4. PubMed ID: 10800617 [TBL] [Abstract][Full Text] [Related]
19. Cellular kinetics of invasive squamous carcinoma of the human cervix. Bennington JL Cancer Res; 1969 May; 29(5):1082-8. PubMed ID: 5781100 [No Abstract] [Full Text] [Related]
20. [Impulse cytophotometric studies on DNA in bladder carcinoma]. Tribukait B; Gustafson H Onkologie; 1980 Dec; 3(6):278-88. PubMed ID: 7012725 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]